Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102613 | PMC |
| http://dx.doi.org/10.3389/fped.2023.1182474 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
This month in JAAD: April 2025.
J Am Acad Dermatol
January 2025
Department of Dermatology and Dermatologic Surgery Medical University of SC; MSC 578, 135 Rutledge Avenue; 11th Floor, Charleston, SC 29425-5780. Electronic address:
Hidradenitis suppurativa.
Lancet
January 2025
Faculty of Medicine, Wroclaw University of Science and Technology, Wrocław, Poland.
Hidradenitis suppurativa is a chronic inflammatory disease characterised by painful, deep-seated nodules, abscesses, and draining tunnels in the skin of axillary, inguinal, genitoanal, or inframammary areas. In recent years, the body of knowledge in hidradenitis suppurativa has advanced greatly. This disorder typically starts in the second or third decade of life.
View Article and Find Full Text PDFInfections in Idiopathic Inflammatory Myopathies: Do Asians Need a Different Dose of Immunosuppression?
Int J Rheum Dis
January 2025
Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.
Images in Dermatology: Showcasing the best of dermatological imaging.
J Eur Acad Dermatol Venereol
February 2025
Dermatology, Pius Hospital de Valls, Valls, Spain.
Management of Systemic Anti-psoriatic Drugs in Psoriasis Patients with Concurrent Paraplegia or Tetraplegia: Insights From a 6-Year Multicenter, Retrospective Observational Study.
Dermatol Ther (Heidelb)
January 2025
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Section of Dermatology, University of Messina, 98125, Messina, Italy.
Introduction: Patients with psoriasis (PsO) and permanent spinal cord injuries (SCI) resulting in paraplegia and tetraplegia may experience a higher rate of infections compared to patients with PsO without SCI. It can result in further challenges for therapeutic management with immunosuppressants (biological and non-biological treatments). Thus, we aimed to evaluate the rate of infections in patients with PsO and SCI treated with systemic immunosuppressants.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!